Non-Viral DNA Delivery and TALEN Editing Correct the Sickle Cell Mutation in Hematopoietic Stem Cells

The authors developed a GMP-compatible TALEN-mediated gene editing process enabling efficient HBB correction via a DNA repair template while minimizing risks associated with HBB inactivation.